Skip to main content

De Sanctis Juan Bautista Ph.D.

Journals

YOUSSEF, M., J. DE SANCTIS, J. SHAH, D. DUMUT, M. HAJDÚCH, A. NAUMOVA, D. RADZIOCH
Treatment of Allergic Asthma With Fenretinide Formulation (LAU-7b) Downregulates ORMDL Sphingolipid Biosynthesis Regulator 3 ( Ormdl3) Expression and Normalizes Ceramide Imbalance. The Journal of Pharmacology and Experimental Therapeutics. 2020, 373(3), 476-487, ISSN: 0022-3565, PMID: 32273303,
YOUSSEF, M., J. DE SANCTIS, C. KANAGARATHAM, S. TAO, E. AHMED, D. RADZIOCH
Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice. Pharmacological Research. 2020, 37(2), 31, ISSN: 0724-8741, PMID: 31915990,
GARIC, D., J. DE SANCTIS, D. DUMUT, J. SHAH, J. PENA, M. YOUSSEF, B. PETROF, F. KOPŘIVA, J. HANRAHAN, M. HAJDÚCH, D. RADZIOCH
Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction. Biochimica et biophysica acta. Molecular and cell biology of lipids. 2019, 1865(2), 158538, ISSN: 1388-1981, PMID: 31678518,

Open positions

Project: Research and development of agents for cancer, neurodegenerative and infectious diseases
Supervisors: De Sanctis Juan Bautista Ph.D., Hajdúch Marián M.D., Ph.D., Džubák Petr M.D., Ph.D., Urban Milan Ph.D., Das Viswanath M.Sc., Ph.D.
Available: 5
Intended for: Doctoral training